(EMAILWIRE.COM, January 12, 2019 ) Factors such as growth in biotech and biopharmaceuticals industries; increasing incidences of chronic diseases; technological advancements in cell-based research instruments, and rising government supports in the form of funds and grants for cell-based research activities are driving the growth of the market.

Don’t miss out on business opportunities in Cell Signaling Market

Availability of funding cell-based research is the key driver for the global cell signaling market

Governments of various countries are promoting and supporting cell-based research activities such as cell signaling, single-cell analysis, and stem cell research. A large portion of the funding from governments is provided to academic research societies to promote cell-based research, which helps in the evaluation of diagnostic and therapeutic applications of various types of cells in the management of chronic and infectious diseases. By driving research into the application and end-user industries for cell analysis, the availability of support plays a significant role in aiding market growth.

Download PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=80206120
Research Application

Research is an important application segment in the cell signaling industry and has witnessed significant growth in recent years owing to the increasing incidence of chronic diseases, technological advancements in cell biology instruments, and increase in the cell-based research activities across the globe.

The rising number of patients suffering from chronic diseases such as cancer, diabetes, cardiovascular disorders, and neurological conditions has led to an increase in cell signaling-based research across the globe. According to the 2014 report of the American Heart Foundation, nearly 17.3 million people die due to cardiovascular diseases (CVDs) each year, accounting for 30% of global deaths.

Speak To Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=80206120

key players in the cell signaling market;

Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.), QIAGEN N.V. (Netherlands), Cell Signaling Technology, Inc. (U.S.), Promega Corporation (U.S.), Bio-Techne Corporation (U.S.)